Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
AssigneeChugai Seiyaku Kabushiki Kaisha
InventorsOsamu Cynshi, Koji Mizuno
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis comprising a therapeutically effective amount of human erythropoietin (EPO) in a parenterally acceptable vehicle is disclosed. Human EPO may be extracted from human urine or also be prepared by expressing in a host cell the gene coding for the amino acid sequence of human EPO.
Claims1
A method for treating the anemia of rheumatoid arthritis in a patient who is suffering from anemia of rheumatoid arthritis which comprises administering to said patient a therapeutically effective amount of human erythropoietin for treating anemia of rheumatoid arthritis in a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.